Investment Director, Biotechnology
UniseedCheck size: Uniseed does not publish a standard check-size range on its current official site.
John Kurek invests or supports investment decisions through Uniseed's published strategy: Commercialise breakthrough deep-tech and life-sciences discoveries from partner universities and CSIRO, supporting companies from research through global scale.
Defensible scientific discoveries, strong intellectual property, clear market problems and teams capable of translating research into global companies.
Uniseed does not invest in pure academic research, predominantly nonprofit ventures or companies without a significant partner-university or CSIRO connection.
Show the partner-institution connection, science and IP, commercial problem, validation plan, team and milestones from research to investable company.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
John Kurek is a current Investment Director, Biotechnology at Uniseed, according to the firm's official roster. No education, prior employment or personal deal claims are inferred where the firm does not publish them.